26 March 2024
| |
Synectics plc
(the "Company")
Director/PDMR Shareholding
Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, announces that it was notified on 25 March 2024 that on the same day Mr Andrew Lockwood, Non-Executive Director of the Company, purchased 8,659 ordinary shares of 20 pence each in the Company ("Ordinary Shares") at a price of 174.012 pence per share.
Following this purchase, Mr Lockwood's interests in Ordinary Shares are as follows:
| Name | Number of Ordinary Shares Held | Resultant Total Interest | % of Issued Share Capital |
| Andrew Lockwood | 8,659 | 8,659 | 0.05 |
For further information, please contact:
| Synectics plc Paul Webb, Chief Executive Officer Amanda Larnder, Chief Financial Officer Claire Stewart, Company Secretary email: info@synecticsplc.com | Tel: +44 (0) 114 280 2828 |
|
|
|
| Shore Capital | Tel: +44 (0) 20 7408 4090 |
| Tom Griffiths / David Coaten / Rachel Goldstein | |
| Vigo Consulting Jeremy Garcia / Fiona Hetherington / Aisling Fitzgerald | Tel: +44 (0) 20 7390 0230 | |
|
| |
|
About Synectics plc
Synectics (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.
The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transport, and critical infrastructure.
Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand-out in its field.
Find out more at www.synecticsplc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.